Compare ACHV & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHV | SMWB |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.5M | 778.8M |
| IPO Year | 2018 | 2021 |
| Metric | ACHV | SMWB |
|---|---|---|
| Price | $8.18 | $8.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $14.67 | $4.00 |
| AVG Volume (30 Days) | ★ 1.4M | 648.3K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.07 |
| Revenue Next Year | N/A | $11.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $2.22 |
| 52 Week High | $8.64 | $9.82 |
| Indicator | ACHV | SMWB |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 49.33 |
| Support Level | $4.03 | $7.83 |
| Resistance Level | $8.63 | $9.30 |
| Average True Range (ATR) | 0.37 | 0.40 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 75.46 | 29.59 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.